Abstract:Pyroptosis is a form of pro-inflammatory cell death that can be mediated by gasdermin D (GSDMD) activation induced by inflammatory caspases such as caspase-1. Emerging evidence suggests that targeting GSDMD activation or pyroptosis may facilitate the reduction of vascular inflammation and atherosclerotic lesion development. The current study investigated the therapeutic effects of inhibition of GSDMD activation by the novel GSDMD inhibitor N-Benzyloxycarbonyl-Leu-Leu-Ser- Asp(OMe)-fluoromethylketone (Z-LLSD-FMK), the specific caspase-1 inhibitor N-Benzyloxycarbonyl-Tyr-Val-Ala-Asp(OMe)-fluoromethylketone (Z-YVAD-FMK), and a combination of both on atherosclerosis in ApoE(-/-) mice fed a western diet at 5 weeks of age, and further determined the efficacy of these polypeptide inhibitors in bone marrow-derived macrophages (BMDMs). In vivo studies there was plaque formation, GSDMD activation, and caspase-1 activation in aortas, which increased gradually from 6 to 18 weeks of age, and increased markedly at 14 and 18 weeks of age. ApoE-/- mice were administered Z-LLSD-FMK (200 mu g/day), Z-YVAD-FMK (200 mu g/day), a combination of both, or vehicle control intraperitoneally from 14 to 18 weeks of age. Treatment significantly reduced lesion formation, macrophage infiltration in lesions, protein levels of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1, and pyroptosis-related proteins such as activated caspase-1, activated GSDMD, cleaved interleukin(IL)-1 beta, and high mobility group box 1 in aortas. No overt differences in plasma lipid contents were detected. In vitro treatment with these polypeptide inhibitors dramatically decreased the percentage of propidium iodide-positive BMDMs, the release of lactate dehydrogenase and IL-1 beta, and protein levels of pyroptosis-related proteins both in supernatants and cell lysates elevated by lipopolysaccharide + nigericin. Notably however, there were no significant differences in the above-mentioned results between the Z-LLSD-FMK group and the Z-YVAD-FMK group, and the combination of both did not yield enhanced effects. These findings indicate that suppression of

Pan-caspase Inhibitor Zvad Enhances Cell Death in RAW246.7 Macrophages.

Apoptosis by Pan-Caspase Inhibitors in Lipopolysaccharide-Activated Macrophages.

Activation of the RON Receptor Tyrosine Kinase Protects Murine Macrophages from Apoptotic Death Induced by Bacterial Lipopolysaccharide.

Zvad Alleviates Experimental Autoimmune Hepatitis in Mice by Increasing the Sensitivity of Macrophage to TNFR1-dependent Necroptosis.

Caspase Inhibitor Z-VAD-FMK Enhances the Freeze-Thaw Survival Rate of Human Embryonic Stem Cells.

Autophagy Contributes to Caspase-independent Macrophage Cell Death

Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner

Caspase Inhibitor Zvad-Fmk Protects Against Acute Pancreatitis-Associated Lung Injury Via Inhibiting Inflammation and Apoptosis

Caspase-1 Inhibition Reduces Occurrence of PANoptosis in Macrophages Infected by E. faecalis OG1RF

Caspase Inhibition Prevents Tumor Necrosis Factor-α–Induced Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes in Vivo and in Vitro

Regulator of G-protein Signaling 19 (RGS19) and Its Partner Gα-inhibiting Activity Polypeptide 3 (GNAI3) Are Required for Zvad-Induced Autophagy and Cell Death in L929 Cells.

Phagocytosis of serum-and IgG-opsonized zymosan particles induces apoptosis through superoxide but not nitric oxide in macrophage J774A.1

Caspase Inhibitor Z-Vad-fmk Increases the Survival of Hair Cells after Actinomycin-D-induced Damage in Vitro

Inflammatory cell death PANoptosis is induced by the anti-cancer curaxin CBL0137 via eliciting the assembly of ZBP1-associated PANoptosome

Tumor necrosis factor-alpha induces caspase-independent cell death in human neutrophils via reactive oxidants and associated with calpain activity

Inhibition of GSDMD activation by Z-LLSD-FMK or Z-YVAD-FMK reduces vascular inflammation and atherosclerotic lesion development in ApoE<SUP>-/-</SUP> mice

Endoplasmic Reticulum Stress Cooperates In Zearalenone-Induced Cell Death Of Raw 264.7 Macrophages

Role of Cyt-C/caspases-9,3, Bax/Bcl-2 and the FAS Death Receptor Pathway in Apoptosis Induced by Zinc Oxide Nanoparticles in Human Aortic Endothelial Cells and the Protective Effect by Alpha-Lipoic Acid

Activation and Caspase-Mediated Inhibition of PARP: a Molecular Switch Between Fibroblast Necrosis and Apoptosis in Death Receptor Signaling.

Caspase activation and cytochrome c release during HL-60 cell apoptosis induced by a nitric oxide donor

Activation-Induced Apoptosis of Mouse Macrophage RAW264.7 by Lipopolysaccharide